ESPR Stock Predictions

Recent ESPR Stock Price   ESPR Stock Predictions
$6.36 ESPR stock predictions: higher
+53.30%
$9.75
 As of 2023-02-01
Recent ESPR Analyst Ratings Breakdown, Making ESPR Stock Predictions
  Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong buy ratings: 2 2 2 2
Buy ratings: 1 1 1 1
Hold ratings: 3 3 3 3
Sell ratings: 1 0 0 0
Strong sell ratings: 1 2 2 2
Average rating: 2.71 2.79 2.79 2.79
In the last row of the above table, the average rating presented is from 1 to 5 where 1 means Strong Buy and 5 means Strong Sell.

For the ESPR stock predictions from the analysts covering Esperion Therapeutics Inc (New), we have collected all of the individual ESPR stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 8 different analysts covering ESPR (as reported in data provided by Zacks Investment Research via Quandl.com).

But since ESPR stock predictions may vary widely, another useful metric to consider is the median ESPR stock prediction, which represents the price at which half of the analysts made ESPR stock predictions that were higher and half made ESPR stock predictions that were lower. This makes for a different take on the ESPR stock predictions out there, as compared to average or mean. And that median across all the individual ESPR stock predictions was: $8.5 as of 2023-02-01.

The very highest of the ESPR stock predictions for one year price target was $22.0, while the very lowest of the ESPR stock predictions in the analyst group was $3.0 (with a standard deviation of $5.994). Get the latest Zacks research report on ESPR — FREE


Find out: ESPR next earnings date »



Slideshow Dividend Growth Stocks: 25 Aristocrats
Slideshow 10 Dividend Bargains You Can Buy Cheaper Than Insiders Did



Other stock predictions:
 • ALE Stock Predictions
 • QUOT Stock Predictions
 • OR Stock Predictions
 • PSTL Stock Predictions
 • TRIP Stock Predictions
 • STXB Stock Predictions
 • STRL Stock Predictions
 • IEA Stock Predictions
 • CRS Stock Predictions

Name: 
Esperion Therapeutics Inc (New)
Website: 
www.esperion.com
Sector: 
Drugs & Pharmaceuticals
Quotes delayed 20 minutes

Hold (2.29 out of 4)
5th percentile
(ranked lower than approx. 95% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com


 
 

ESPR Stock Predictions | www.TopDividends.com | Copyright © 2020 - 2023, All Rights Reserved

Nothing in this site or parent site DividendChannel.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent. Contact Dividend Channel; Meet Our Editorial Staff.